Oct 2026· Biochemical Pharmacology· pp.
118563
· 0 citations· 48 references
Medicine
TL;DR
It is indicated that circNFIB attenuates H/R-induced ferroptosis in AC16 cells, with the miR-338-3p/GPX4 pathway contributing to this effect.
Abstract
Cardiomyocyte ferroptosis contributes to myocardial ischemia/reperfusion injury, but the upstream noncoding RNA mechanisms remain incompletely defined. This study examined whether nuclear factor I B-derived circular RNA (circNFIB) regulates hypoxia/reoxygenation (H/R)-induced ferroptosis in human ventricular cardiomyocyte-derived AC16 cells and whether the miR-338-3p/GPX4 pathway contributes to this effect. The circNFIB back-splice junction was verified by Sanger sequencing. Cell viability, malondialdehyde, intracellular Fe2+, boron-dipyrromethene (BODIPY) 581/591 C11 oxidation, and glutathione peroxidase 4 (GPX4), acyl-CoA synthetase long-chain family member 4 (ACSL4), and transferrin receptor 1 (TfR1) protein abundance were evaluated. H/R decreased circNFIB expression, cell viability, and GPX4 abundance, while increasing lipid peroxidation, intracellular Fe2+ accumulation, and ACSL4 abundance; the reference ferroptosis inhibitor ferrostatin-1 partially reversed these changes. circNFIB overexpression improved cell viability, reduced intracellular Fe2+ accumulation and lipid peroxidation, partially restored GPX4 protein abundance, and lowered ACSL4 and TfR1 abundance. circNFIB was predominantly cytoplasmic. In reporter assays, miR-338-3p decreased the activity of reporters containing the wild-type circNFIB sequence or GPX4 3' untranslated region (3'UTR), whereas no significant reductions were observed with the corresponding mutant reporters. H/R increased miR-338-3p expression, whereas circNFIB overexpression reduced it. miR-338-3p overexpression aggravated the ferroptosis-associated phenotype and partially counteracted the protection associated with circNFIB overexpression. These findings indicate that circNFIB attenuates H/R-induced ferroptosis in AC16 cells, with the miR-338-3p/GPX4 pathway contributing to this effect.
Remimazolam (RMZ) is an ultra-short-acting sedative anesthetic that provides protection against cerebral and hepatic ischemia/reperfusion injury. However, its potential cardioprotective effect in myocardial ischemia reperfusion injury (MIRI) remains to be fully elucidated. The present study investigated the hypothesis...
Xi-Yuan Chen, Jiang-Hong Zhao, Xing He et al.· International Journal of Mol...· 0 citations
Luteolin attenuates hypoxia-induced ferroptosis-associated changes in human brain microvascular endothelial cells by restoring redox homeostasis and is associated with coordinated modulation of the PPARγ/FABP5/ALOX15 pathway.
Sirirak Mukem, Patcharakorn Kiatamornrak, S. Suwansa-ard et al.· Biomedicines· 0 citations
Hepatic ischemia-reperfusion injury (HIRI) is a complex clinical complication involving inflammation and multiple forms of regulated cell death, among which ferroptosis plays a critical role. Ginsenoside Re (Re) exhibits prominent antioxidant capabilities, but its exact molecular targets in HIRI are unidentified. Here,...
Ting-Feng Yang, Shao-Hua Zhang, Dan-Na Xie et al.· International Immunopharmaco...· 0 citations
Myocardial ischemia/reperfusion (I/R) injury is closely associated with excessive oxidative stress and ferroptosis. Salidroside (Sal), a major active component of Rhodiola, has demonstrated cardioprotective properties, yet its precise mechanisms in regulating ferroptosis remain unclear. The present study investigated w...
Zhi-Cong Qiu, J. Li, Yi-Zhou Li et al.· International Journal of Mol...· 0 citations
Cerebral ischemic preconditioning (CIP) confers robust protection against subsequent ischemic stroke by enhancing brain ischemic tolerance. Although ferroptosis is increasingly recognized as a critical pathogenic mechanism in stroke, the role of N6-methyladenosine (m6A) RNA modification in its regulation remains poorly...
Yu-Ping Zhang, Ling-Yan Zhang, Xi-Yun Liu et al.· Neuropharmacology· 0 citations
Cerebral ischemia-reperfusion injury (CIRI) is a leading cause of neurological disability with few effective therapeutic strategies, and ferroptosis has been proven to participate in CIRI progression while its upstream regulatory mechanisms remain poorly defined. Herein, we performed transcriptomic analysis on GSE16207...
Hai-Ning Wang, Bai-Chao Han, Chen Xu et al.· Archives of Biochemistry and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.